The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2022 / Oct / The Dual Sourcing Approach
Business & Regulation Supply Chain Outsourcing Technology & Manufacturing Packaging Sponsored

The Dual Sourcing Approach

How robust is your strategy? Are you prepared for supply chain interruption? In today’s turbulent world, risk mitigation strategies are a must – and having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines is no longer a ‘nice to have’. It should be an essential part of your strategy in terms of patient health.

10/20/2022 1 min read

Sponsored By

Share

Whether they know it or not, patients are heavily reliant on complex supply chains for sometimes life-saving medications – and that’s why good supply chain management has always been important for the industry, particularly in the case of critical medicines. However, the COVID-19 pandemic, natural disasters, the war in Ukraine, disruption in labor through staff shortages, and other events in recent years have emphasized how vulnerable the industry’s supply chains truly are and underlined the crucial importance of robust risk mitigation strategies. In addition, the threat of disruption in the supply of equipment, components, and materials – including raw materials – is also a significant risk.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

When every component matters, how do you make quality predictable?
Packaging
When Every Component Matters: Quality in Injectable Drug Packaging

November 17, 2026

5 min read

Estelle Verger and Nicolas Voisin from Aptar Pharma’s Injectables business discuss component quality, the changing needs of injectable therapies, and what to expect from a component partner.

Video: Sitting Down With… Delara Motlagh
Cell & Gene Bioprocessing Outsourcing
Video: Sitting Down With… Delara Motlagh

November 13, 2026

1 min read

Fujifilm Cellular Dynamics’ Delara Motlagh discusses her path into cell and gene therapy, the challenges of scaling manufacturing, and the potential of iPSC technologies

Lonza to Acquire Five US CDMO Sites from Merck KGaA
Biopharma Bioprocessing Industry News
Lonza to Acquire Five US CDMO Sites from Merck KGaA

November 11, 2026

2 min read

The deal adds viral vector, bioconjugation, payload-linker, and advanced drug-delivery capabilities to Lonza’s manufacturing network

Strategic Development of Complex Oral Therapies
Formulation Small Molecules Development & Clinical
Strategic Development of Complex Oral Therapies

November 2, 2026

5 min read

Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: